AG205, a novel agent directed against FabK of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 8, 2006, Pages 2869-2871

  Takahata, Sho ^a   Iida, Maiko ^a   Osaki, Yumi ^a   Saito, Jun ^a   Kitagawa, Hideo ^a   Ozawa, Tomohiro ^a   Yoshida, Takuji ^a   Hoshiko, Shigeru ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL CARRIER PROTEIN; AE 848; AG 205; ALANINE; ENZYME INHIBITOR; OXIDOREDUCTASE; SERINE; TRICLOSAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; DRUG IDENTIFICATION; ENZYME ACTIVITY; FABK GENE; GENE; GENE AMPLIFICATION; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; LIPOGENESIS; MACROMOLECULE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); ENZYME INHIBITORS; ESCHERICHIA COLI; GENES, BACTERIAL; HUMANS; INHIBITORY CONCENTRATION 50; LIPOGENESIS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; SERINE; STREPTOCOCCUS PNEUMONIAE; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

EID: 33746892678     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00270-06     Document Type: Article

References (15)

1. Heath, R. J., J. Li, G. E. Roland, and C. O. Rock. 2000. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J. Biol. Chem. 275:4654-4659.
2. Heath, R. J., and C. O. Rock. 1995. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J. Biol. Chem. 270:26538-26542.
3. Heath, R. J., and C. O. Rock. 2000. A triclosan-resistant bacterial enzyme. Nature 406:145-146.
4. Heath, R. J., S. W. White, and C. O. Rock. 2001. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40:467-497.
5. Heath, R. J., Y.-T. Yu, M. A. Shapiro, E. Olson, and C. O. Rock. 1998. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J. Biol. Chem. 273:30316-30320.
6. Heerding, D. A., G. Chan, W. E. DeWolf, Jr., A. P. Fosberry, C. A. Janson, D. D. Jaworski, E. McManus, W. H. Miller, T. D. Moore, D. J. Payne, X. Qiu, S. F. Rittenhouse, C. Slater-Radosti, W. Smith, D. T. Takata, K. S. Vaidya, C. C. K. Yuan, and W. F. Huffman. 2001. 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorg. Med. Chem. Lett. 11:2061-2065.
7. Li, Q., J. Y. Lee, R. Castillo, M. S. Hixon, C. Pujol, V. R. Doppalapudi, H. M. Shepard, G. M. Wahl, T. J. Lobl, and M. F. Chan. 2002. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against β-lactamase-producing strains. Antimicrob. Agents Chemother. 46:1262-1268.
8. Ling, L. L., J. Xian, S. Ali, B. Geng, J. Fan, D. M. Mills, A. C. Arvanites, H. Orgueira, M. A. Ashwell, G. Carmel, Y. Xiang, and D. T. Moir. 2004. Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase. Antimicrob. Agents Chemother. 48:1541-1547.
9. Marrakchi, H., W. E. DeWolf, Jr., C. Quinn, J. West, B. J. Polizzi, C. Y. So, D. J. Holmes, S. L. Reed, R. J. Heath, D. J. Payne, C. O. Rock, and N. G. Wallis. 2003. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK). Biochem. J. 370:1055-1062.
10. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Payne, D. J., W. H. Miller, V. Berry, J. Brosky, W. J. Burgess, E. Chen, W. E. DeWolf, Jr., A. P. Fosberry, R. Greenwood, M. S. Head, D. A. Heerding, C. A. Janson, D. D. Jaworski, P. M. Keller, P. J. Manley, T. D. Moore, K. A. Newlander, S. Pearson, B. J. Polizzi, X. Qiu, S. F. Rittenhouse, C. Slater-Radosti, K. L. Salyers, M. A. Seefeld, M. G. Smyth, D. T. Takata, I. N. Uzinskas, K. Vaidya, N. G. Wallis, S. B. Winram, C. C. K. Yuan, and W. F. Huffman. 2002. Discovery of a novel and potent class of FabI-directed antibacterial agents. Antimicrob. Agents Chemother. 46:3118-3124.
12. Quemard, A., J. C. Sacchettini, A. Dessen, C. Vilcheze, R. Bittman, W. R. Jacobs, Jr., and J. S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
13. Seefeld, M. A., W. H. Miller, K. A. Newlander, W. J. Burgess, W. E. DeWolf, Jr., P. A. Elkins, M. S. Head, D. R. Jakas, C. A. Janson, P. M. Keller, P. J. Manley, T. D. Moore, D. J. Payne, S. Pearson, B. J. Polizzi, X. Qiu, S. F. Rittenhouse, I. N. Uzinskas, N. G. Wallis, and W. F. Huffman. 2003. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK. J. Med. Chem. 46:1627-1635.
14. Seefeld, M. A., W. H. Miller, K. A. Newlander, W. J. Burgess, D. J. Payne, S. F. Rittenhouse, T. D. Moore, W. E. DeWolf, Jr., P. M. Keller, X. Qiu, C. A. Janson, K. Vaidya, A. P. Fosberry, M. G. Smyth, D. D. Jaworski, C. Slater-Radosti, and W. F. Huffman. 2001. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3, 4-5]indoles as potential antibacterial agents. Bioorg. Med. Chem. Lett. 11:2241-2244.
15. Slater-Radosti, C., G. Van Aller, R. Greenwood, R. Nicholas, P. M. Keller, W. E. DeWolf, Jr., F. Fan, D. J. Payne, and D. D. Jaworski. 2001. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J. Antimicrob. Chemother. 48:1-6.